State of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures

Simple item page
dc.catalogadorasg
dc.contributor.authorEspinosa-Bustos, C.
dc.contributor.authorMella, J.
dc.contributor.authorSoto-Delgado, J.
dc.contributor.authorSalas Sanchez, Cristian Osvaldo
dc.date.accessioned2024-03-04T15:12:32Z
dc.date.available2024-03-04T15:12:32Z
dc.date.issued2019
dc.fuente.origenORCID
dc.identifier.doi10.4155/fmc-2018-0497
dc.identifier.urihttps://doi.org/10.4155/fmc-2018-0497
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-85064121690&partnerID=MN8TOARS
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/81609
dc.information.autorucEscuela de Química; Salas Sanchez, Cristian Osvaldo; 0000-0001-7620-2459; 101425
dc.language.isoen
dc.rightsregistro bibliográfico
dc.titleState of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures
dc.typeartículo
sipa.codpersvinculados101425
sipa.trazabilidadORCID;2024-01-22
Files
Collections
Artículos de revistas